View in EDS HTML Full Text PDF Full Text

Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapy.

Saved in:
Bibliographic Details
Title: Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapy.
Authors: Boytz R; National Emerging Infectious Diseases Laboratories, Department of Microbiology, Boston University, Boston, Massachusetts, USA., Słabicki M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Ramaswamy S; Department of Microbiology, Boston University, Boston, Massachusetts, USA., Patten JJ; National Emerging Infectious Diseases Laboratories, Department of Microbiology, Boston University, Boston, Massachusetts, USA., Zou C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Meng C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Hurst BL; Institute for Antiviral Research, Utah State University, Logan, Utah, USA., Wang J; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Nowak RP; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Yang PL; Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA., Sattler M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Stone RM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Griffin JD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Gray NS; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA., Gummuluru S; Department of Microbiology, Boston University, Boston, Massachusetts, USA., Davey RA; National Emerging Infectious Diseases Laboratories, Department of Microbiology, Boston University, Boston, Massachusetts, USA., Weisberg E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Source: Journal of medical virology [J Med Virol] 2023 Jan; Vol. 95 (1), pp. e28157. Date of Electronic Publication: 2022 Sep 28.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36117402
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Boytz+R%22">Boytz R</searchLink>; National Emerging Infectious Diseases Laboratories, Department of Microbiology, Boston University, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Słabicki+M%22">Słabicki M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ramaswamy+S%22">Ramaswamy S</searchLink>; Department of Microbiology, Boston University, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Patten+JJ%22">Patten JJ</searchLink>; National Emerging Infectious Diseases Laboratories, Department of Microbiology, Boston University, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Zou+C%22">Zou C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Meng+C%22">Meng C</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Hurst+BL%22">Hurst BL</searchLink>; Institute for Antiviral Research, Utah State University, Logan, Utah, USA.<br /><searchLink fieldCode="AU" term="%22Wang+J%22">Wang J</searchLink>; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Nowak+RP%22">Nowak RP</searchLink>; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Yang+PL%22">Yang PL</searchLink>; Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Sattler+M%22">Sattler M</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Stone+RM%22">Stone RM</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Griffin+JD%22">Griffin JD</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Gray+NS%22">Gray NS</searchLink>; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Gummuluru+S%22">Gummuluru S</searchLink>; Department of Microbiology, Boston University, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Davey+RA%22">Davey RA</searchLink>; National Emerging Infectious Diseases Laboratories, Department of Microbiology, Boston University, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Weisberg+E%22">Weisberg E</searchLink>; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227705876%22">Journal of medical virology</searchLink> [J Med Virol] 2023 Jan; Vol. 95 (1), pp. e28157. <i>Date of Electronic Publication: </i>2022 Sep 28.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7705876 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1096-9071 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201466615%22">01466615 </searchLink><i>NLM ISO Abbreviation: </i>J Med Virol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36117402
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jmv.28157
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e28157
    Titles:
      – TitleFull: Anti-SARS-CoV-2 activity of targeted kinase inhibitors: Repurposing clinically available drugs for COVID-19 therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Boytz R
      – PersonEntity:
          Name:
            NameFull: Słabicki M
      – PersonEntity:
          Name:
            NameFull: Ramaswamy S
      – PersonEntity:
          Name:
            NameFull: Patten JJ
      – PersonEntity:
          Name:
            NameFull: Zou C
      – PersonEntity:
          Name:
            NameFull: Meng C
      – PersonEntity:
          Name:
            NameFull: Hurst BL
      – PersonEntity:
          Name:
            NameFull: Wang J
      – PersonEntity:
          Name:
            NameFull: Nowak RP
      – PersonEntity:
          Name:
            NameFull: Yang PL
      – PersonEntity:
          Name:
            NameFull: Sattler M
      – PersonEntity:
          Name:
            NameFull: Stone RM
      – PersonEntity:
          Name:
            NameFull: Griffin JD
      – PersonEntity:
          Name:
            NameFull: Gray NS
      – PersonEntity:
          Name:
            NameFull: Gummuluru S
      – PersonEntity:
          Name:
            NameFull: Davey RA
      – PersonEntity:
          Name:
            NameFull: Weisberg E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2023 Jan
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1096-9071
          Numbering:
            – Type: volume
              Value: 95
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of medical virology
              Type: main
ResultId 1